Gilead Sciences (GILD) EV to CFO (2009 - 2026)
Gilead Sciences' (GILD) EV to CFO was 12.78 for Q3 2026, down 5.3% from 13.49 a year earlier but up 12.8% from the prior quarter.
Powered by 
Analysis
Gilead Sciences (GILD) EV to CFO (2009 - 2026) Analysis & Trends
For FY2025, EV to CFO at Gilead Sciences was 14.43, up 48.8% from FY2024.
- By year, EV to CFO came in at 9.70 in FY2024 (-17.0%), 11.69 in FY2023 (+5.4%), 11.09 in FY2022 (+49.4%) and 7.43 in FY2021 (-7.6%).
- Five-year quarterly EV to CFO spans a low of 6.53 in Q1 2022 and a high of 15.30 in Q1 2026.
- Year over year, EV to CFO gained in five of the last eight quarters, with growth averaging 14.2%.
- The high point for year-over-year EV to CFO in five years was Q1 2023 (growth of 66.6%); the low point was Q1 2022 (a decline of 19.1%).
- Per Business Quant data, the three quarters before Q3 2026 came in at 11.33 (Q2 2026), 15.30 (Q1 2026) and 14.43 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn |
| 10 | Vertex Pharmaceuticals | 139.96 Bn | 111.95 Bn | 2.91 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 12.32 |
| Jun 30, 2026 | 11.33 |
| Mar 31, 2026 | 15.30 |
| Dec 31, 2025 | 14.43 |
| Sep 30, 2025 | 13.49 |
| Jun 30, 2025 | 13.42 |
| Mar 31, 2025 | 12.68 |
| Dec 31, 2024 | 9.70 |
| Sep 30, 2024 | 9.91 |
| Jun 30, 2024 | 11.06 |
| Mar 31, 2024 | 10.20 |
| Dec 31, 2023 | 11.69 |
| Sep 30, 2023 | 10.29 |
| Jun 30, 2023 | 9.40 |
| Mar 31, 2023 | 10.88 |
| Dec 31, 2022 | 11.09 |
| Sep 30, 2022 | 7.38 |
| Jun 30, 2022 | 7.11 |
| Mar 31, 2022 | 6.53 |
| Dec 31, 2021 | 7.43 |
API Access
Gilead Sciences EV to CFO API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-cfo", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();